Registered number
08793953
Pharmastat Consulting Ltd
Filleted Accounts
30 November 2024
Pharmastat Consulting Ltd
Registered number: 08793953
Balance Sheet
as at 30 November 2024
Notes 2024 2023
£ £
Current assets
Debtors 4 14,535 25,654
Cash at bank and in hand 86,205 112,111
100,740 137,765
Creditors: amounts falling due within one year 5 (41,838) (47,522)
Net current assets 58,902 90,243
Net assets 58,902 90,243
Capital and reserves
Called up share capital 1 1
Profit and loss account 58,901 90,242
Shareholders' funds 58,902 90,243
The directors are satisfied that the company is entitled to exemption from the requirement to obtain an audit under section 477 of the Companies Act 2006.
The members have not required the company to obtain an audit in accordance with section 476 of the Act.
The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
The accounts have been prepared and delivered in accordance with the special provisions applicable to companies subject to the small companies regime. The profit and loss account has not been delivered to the Registrar of Companies.
John Breddy
Director
Approved by the board on 28 February 2024
Pharmastat Consulting Ltd
Notes to the Accounts
for the year ended 30 November 2024
1 Accounting policies
Basis of preparation
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, The Financial Reporting Standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).
Turnover
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services. Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have transferred to the buyer. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
Tangible fixed assets
Tangible fixed assets are measured at cost less accumulative depreciation and any accumulative impairment losses. Depreciation is provided on all tangible fixed assets, other than freehold land, at rates calculated to write off the cost, less estimated residual value, of each asset evenly over its expected useful life, as follows:
Software and equipment. 25%
Debtors
Short term debtors are measured at transaction price which is usually the invoice price.
Creditors
Short term creditors are measured at transaction price which is usually the invoice price.
Taxation
A current tax liability is recognised for the tax payable on the taxable profit of the current and past periods.Current and deferred tax ax asset s and liabilities are not discounted.
Pensions
Contributions to defined contribution plans are expensed in the period to which they relate.
2 Employees 2024 2023
Number Number
Average number of persons employed by the company 1 1
3 Tangible fixed assets
Software & equipment
£
Cost
At 1 December 2023 16,931
At 30 November 2024 16,931
Depreciation
At 1 December 2023 16,931
At 30 November 2024 16,931
Net book value
At 30 November 2024 -
4 Debtors 2024 2023
£ £
Trade debtors 14,535 25,654
5 Creditors: amounts falling due within one year 2024 2023
£ £
Taxation and social security costs 30,562 36,277
Other creditors 11,276 11,245
41,838 47,522
6 Related party transactions
John Breddy is the director of the company. Amounts due to him £2,637 (2023 -£2,606). Dividends paid to him were £110,000 (2023 - £110,000).
7 Controlling party
The company is controlled by John Breddy by virtue of his shareholding.
8 Other information
Pharmastat Consulting Ltd is a private company limited by shares and incorporated in England. Its registered office is:
27 River Court
Chartham
Canterbury
CT4 7JN
Pharmastat Consulting Ltd 08793953 false 2023-12-01 2024-11-30 2024-11-30 VT Final Accounts April 2024 John Breddy No description of principal activity 08793953 2022-12-01 2023-11-30 08793953 core:WithinOneYear 2023-11-30 08793953 core:ShareCapital 2023-11-30 08793953 core:RetainedEarningsAccumulatedLosses 2023-11-30 08793953 2023-12-01 2024-11-30 08793953 bus:PrivateLimitedCompanyLtd 2023-12-01 2024-11-30 08793953 bus:AuditExempt-NoAccountantsReport 2023-12-01 2024-11-30 08793953 bus:Director40 2023-12-01 2024-11-30 08793953 1 2023-12-01 2024-11-30 08793953 2 2023-12-01 2024-11-30 08793953 countries:England 2023-12-01 2024-11-30 08793953 bus:FRS102 2023-12-01 2024-11-30 08793953 bus:FilletedAccounts 2023-12-01 2024-11-30 08793953 2024-11-30 08793953 core:WithinOneYear 2024-11-30 08793953 core:ShareCapital 2024-11-30 08793953 core:RetainedEarningsAccumulatedLosses 2024-11-30 08793953 core:PlantMachinery 2024-11-30 08793953 2023-11-30 08793953 core:PlantMachinery 2023-11-30 iso4217:GBP xbrli:pure